Nizonide DT 200 mg (Nitazoxanide) – Dispersible Antiparasitic Tablet
Buy Nizonide DT 200 mg (Nitazoxanide) from Tabexports – Worldwide Pharmaceutical Exporter
Nizonide DT 200 mg (Nitazoxanide) is a dispersible tablet formulation used in the treatment of protozoal and intestinal parasitic infections. The DT (dispersible tablet) form allows easy administration, especially for pediatric and patients with swallowing difficulties, when prescribed by a healthcare professional.
Tabexports supplies Nizonide DT 200 mg tablets for bulk and wholesale export, ensuring export-compliant packaging, regulatory documentation, and reliable worldwide logistics.
Active Ingredient
Nitazoxanide 200 mg
Nitazoxanide is a broad-spectrum antiparasitic agent effective against protozoa and certain helminths by inhibiting essential anaerobic metabolic pathways.
Product Highlights
✔ Nitazoxanide 200 mg dispersible tablet
✔ Easy-to-administer DT formulation
✔ Broad-spectrum antiparasitic & antiprotozoal activity
✔ Commonly used in intestinal infections (as prescribed)
✔ Export-ready international packaging
✔ Bulk & wholesale supply available worldwide
Mechanism of Action
Nitazoxanide works by:
-
Inhibiting parasite energy metabolism
-
Blocking pyruvate-dependent enzymatic pathways
-
Preventing parasite growth and survival
Use strictly under professional medical supervision.
Dosage & Administration
-
Disperse tablet in a small amount of water before administration
-
Dosage as directed by a licensed healthcare professional
-
Depends on patient age, weight, and infection type
-
Complete the full prescribed treatment course
Storage & Safety Information
-
Store in a cool, dry place
-
Protect from moisture and direct sunlight
-
Keep out of reach of children
-
Prescription use only
Why Choose Tabexports?
🌍 Trusted global pharmaceutical exporter
📦 Export-grade packaging & regulatory documentation
🚚 Reliable international shipping network
🏭 Quality-focused sourcing standards
📈 Bulk supply for distributors, hospitals & NGOs





Reviews
There are no reviews yet.